demonstrated that FTO inhibition suppresses melanoma tumorigenicity and the expression of melanoma cell-intrinsic genes PD-1 (PDCD1), CXCR4, and SOX10 through an m6A dependent, YTHDF2-mediated mRNA decay. This evidence concerns the gene CXCR4 and melanoma.